Allspring Global Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $252K | Sell |
10,844
-644
| -6% | -$15K | ﹤0.01% | 1509 |
|
2025
Q1 | $277K | Buy |
+11,488
| New | +$277K | ﹤0.01% | 1600 |
|
2024
Q4 | – | Sell |
-100,181
| Closed | -$1.51M | – | 2228 |
|
2024
Q3 | $1.51M | Buy |
100,181
+93,497
| +1,399% | +$1.41M | ﹤0.01% | 1235 |
|
2024
Q2 | $191K | Sell |
6,684
-3,504
| -34% | -$100K | ﹤0.01% | 1717 |
|
2024
Q1 | $298K | Buy |
10,188
+5,433
| +114% | +$159K | ﹤0.01% | 1631 |
|
2023
Q4 | $160K | Buy |
4,755
+274
| +6% | +$9.25K | ﹤0.01% | 1724 |
|
2023
Q3 | $137K | Buy |
4,481
+1,736
| +63% | +$53.3K | ﹤0.01% | 1880 |
|
2023
Q2 | $110K | Sell |
2,745
-77,244
| -97% | -$3.1M | ﹤0.01% | 2012 |
|
2023
Q1 | $3.26M | Buy |
79,989
+39,973
| +100% | +$1.63M | 0.01% | 1108 |
|
2022
Q4 | $1.55M | Sell |
40,016
-186,748
| -82% | -$7.21M | ﹤0.01% | 1312 |
|
2022
Q3 | $12.1M | Sell |
226,764
-11,863
| -5% | -$631K | 0.02% | 708 |
|
2022
Q2 | $13.9M | Buy |
238,627
+148,043
| +163% | +$8.63M | 0.02% | 688 |
|
2022
Q1 | $6.91M | Sell |
90,584
-4,407
| -5% | -$336K | 0.01% | 1018 |
|
2021
Q4 | $5.71M | Buy |
+94,991
| New | +$5.71M | 0.01% | 1129 |
|